 results of the participants with diabetes were reported separately. All included studies were assessed for quality and risk
of bias with the following instruments, depending on the
type of study: Quality in Prognosis Studies, the revised quality appraisal tool for studies of diagnostic reliability,
ROBINS-I (for assessing risk of bias in non-randomised
studies of interventions), the Newcastle-Ottawa Scale (for
non-randomised studies, including observational and
cohort studies where details regarding allocation to intervention